Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Medicale (MCLE) EBITDA Margin (2025)

Medicale (MCLE) has disclosed EBITDA Margin for 1 consecutive years, with 3942.77% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, EBITDA Margin changed N/A year-over-year to 3942.77%, compared with a TTM value of 21064.78% through Sep 2025, changed N/A, and an annual FY2025 reading of 21064.78%, changed N/A over the prior year.
  • EBITDA Margin was 3942.77% for Q1 2025 at Medicale.
  • Across five years, EBITDA Margin topped out at 3942.77% in Q1 2025 and bottomed at 3942.77% in Q1 2025.